详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Regulatory T cells: a new therapeutic link for Sjogren syndrome?

73| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

单位： [1]Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [2]Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出处：

DOI：

ISSN：

关键词： SS regulatory T cells autoimmunity immunotherapy

摘要：

Great advancements have been made in understanding the pathogenesis of SS, but there remain unmet needs for effective and targeted treatments. Glandular and extraglandular dysfunction in SS is associated with autoimmune lymphocytic infiltration that invades the epithelial structures of affected organs. Regulatory T (Treg) cells are a subset of CD4+ T lymphocytes that maintain self-tolerance during physiological conditions. Besides inhibiting excessive inflammation and autoimmune response by targeting various immune cell subsets and tissues, Treg cells have also been shown to promote tissue repair and regeneration in pathogenic milieus. The changes of quantity and function of Treg cells in various autoimmune and chronic inflammatory disorders have been reported, owing to their effects on immune regulation. Here we summarize the recent findings from murine models and clinical data about the dysfunction of Treg cells in SS pathogenesis and discuss the therapeutic strategies of direct or indirect targeting of Treg cells in SS. Understanding the current knowledge of Treg cells in the development of SS will be important to elucidate disease pathogenesis and may guide research for successful therapeutic intervention in this disease.© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 2 区风湿病学

最新[2025]版：

大类 | 2 区医学

小类 | 2 区风湿病学

JCR分区：

出版当年[2021]版：

Q1 RHEUMATOLOGY

最新[2023]版：

Q1 RHEUMATOLOGY

影响因子： 4.7 最新[2023版] 5.3 最新五年平均 7.046 出版当年[2021版] 7.156 出版当年五年平均 7.58 出版前一年[2020版] 5.5 出版后一年[2022版]

第一作者：

第一作者单位： [1]Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

共同第一作者：

通讯作者：

通讯机构： [1]Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [*1]Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Effects of allergen immunotherapy on follicular regulatory T cells [2]Follicular regulatory T cells: a novel target for immunotherapy? [3]Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells [4]Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy [5]Allergen immunotherapy improves defective follicular regulatory T cells in patients with allergic rhinitis [6]The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma [7]Memory CD4(+) T cells are suppressed by CD8(+) regulatory T cells in vitro and in vivo [8]Suppression of Allogeneic T Cells Proliferation by CD3/CD46-Induced T-regulatory 1 Cells [9]Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells [10]Memory CD4+ T cells are suppressed by CD8+ regulatory T cells in vitro and in vivo.